Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Novartis AG ADS
(NY:
NVS
)
74.15
USD
UNCHANGED
Official Closing Price
/ Updated:
6:40 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Novartis AG ADS
< Previous
1
2
3
4
5
6
7
8
9
...
76
77
Next >
Mylan (MYL) Launches Generic Diovan HCT Tabs in U.S.
September 21, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7743366 for the full story.
Read More
from
StreetInsider.com News Articles
Recent 52-Week High Exceeded in Shares of Novartis (NVS)
September 21, 2012
from
Comtex SmarTrend® News Briefs
Novartis (NVS) Receives Positive EMA CHMP Opinion for Votubia as Kidney Tumor Treatment in TSC Patients
September 21, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7742974 for the full story.
Read More
from
StreetInsider.com News Articles
Multiple sclerosis drugs seen gaining traction
September 20, 2012
As a series of drugs used to treat the debilitating disease, once thought untreatable, gain traction in pharmaceutical labs, they’ve caught the eye of Wall Street.
Read More
category
BTK BIIB GILD
,
Biotechnology
,
General
, and 10 more.
from
MarketWatch
Researchers Find Antibody That Might Help Prevent, Cure Flu
September 17, 2012
Read More
category
NYSE:NVS
,
NYSE:SNY
,
NYSE:GSK
, and 2 more.
from
InvestorPlace - Latest Headlines
Notable Analyst Rating Changes 09/17: (TSLA) (NVS) (MCO) Upgraded; (CYS) (CLF) (AKS) Downgraded
September 17, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7730790 for the full story.
Read More
from
StreetInsider.com News Articles
Exane BNP Paribas Upgrades Novartis (NVS) to Outperform
September 17, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7729841 for the full story.
Read More
from
StreetInsider.com News Articles
FDA Approves Second Multiple Sclerosis Pill
September 13, 2012
Read More
category
NYSE:NVS
,
NYSE:SNY
,
NASDAQ:BIIB
, and 2 more.
from
InvestorPlace - Latest Headlines
Sanofi (SNY) Ticks Higher; Genzyme Gets FDA Approval for New MS Drug
September 13, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7724055 for the full story.
Read More
from
StreetInsider.com News Articles
VGK, NVS, BP, GSK: Large Inflows Detected at ETF
September 12, 2012
Symbols mentioned in this story: VGK, NVS, BP, GSK Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Read More
category
ETFs
from
ETF Channel
Jefferies on Pharmaceutical: Top Picks Still ABT and NVS
September 12, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7720477 for the full story.
Read More
from
StreetInsider.com News Articles
Europe stocks wobble as ESM ruling looms
September 12, 2012
European stock markets struggle for direction in early trade on Wednesday, as investors get jittery ahead of the German constitutional court ruling on the fate of the euro zone’s permanent rescue...
Read More
category
LVMHF
,
UK:BP/
,
Markets/Exchanges
, and 30 more.
from
MarketWatch
Europe stocks lower ahead of key events
September 10, 2012
European stock markets move lower in early action on Monday, as investors remain cautious ahead of Germany’s constitutional-court ruling and policy decisions in the U.S. later in the week.
Read More
category
HK:5
,
TOT
,
Banks
, and 29 more.
from
MarketWatch
Look for dividend income from European stocks
September 07, 2012
Many opportunistic investors, along with money managers who include Europe in a diversified global portfolio, are drawn to beaten-down European stocks. The more cautious among them seek a cushion...
Read More
category
Earnings
,
Banks
,
Mutual Funds
, and 68 more.
from
MarketWatch
10 popular stocks where ‘crowded’ trade hikes risk
September 06, 2012
When the stock market undergoes a shock, beware of a stampede out of stocks in which institutional investors have a high ownership level and that carry a top rating from Wall Street analysts.
Read More
category
PHG
,
TOT
,
MS
, and 42 more.
from
MarketWatch
A Two-Faced Strategy to Playing the Election
September 05, 2012
Investors can probably expect solid gains for their 2012 stock portfolios. But the fortunes of individual sectors will also rise and fall in the years ahead, depending on which political party wins the...
Read More
category
Investing/Investment Analysts
,
Energy/Oil and Gas
,
Politics and Government/Laws and Legislation/Regulations
, and 15 more.
from
CNBC.com News
Pfizer Wins FDA Approval for Chronic Leukemia Drug
September 05, 2012
Read More
category
NYSE:NVS
,
NASDAQ:ARIA
,
NYSE:PFE
, and 2 more.
from
InvestorPlace - Latest Headlines
Novartis International BioCamp Highlights Global RandD Reach to Meet Patient Needs in Emerging Markets
August 29, 2012
Novartis welcomed its annual International Biotechnology Leadership Camp (BioCamp), a three-day seminar bringing biotechnology and business experts together with 60 selected students from leading...
Read More
category
Major Drugs
,
Healthcare
,
Research
from
1888PressRelease - Full Feed
Novartis drug Jakavi® first medication to receive European Commission approval to treat patients with myelofibrosis
August 28, 2012
ovartis received approval today from the European Commission for Jakavi® (INC424, ruxolitinib), a JAK 1 and JAK 2 inhibitor for the treatment of disease-related splenomegaly or symptoms in adult...
Read More
category
Approval
,
Major Drugs
,
Healthcare
from
1888PressRelease - Full Feed
Novartis Drug Shows Promise in Heart Failure
August 27, 2012
Read More
category
NYSE:NVS
,
Market Insight: Financial Articles
from
InvestorPlace - Latest Headlines
New Novartis Phase II data show LCZ696 may provide clinical benefits in patients with a difficult-to-treat form of heart failure
August 27, 2012
Novartis today announced results from the Phase II PARAMOUNT study showing that the investigational compound LCZ696 is the first therapy to significantly reduce a key predictor of morbidity and...
Read More
category
Announcement
,
Major Drugs
,
Healthcare
from
1888PressRelease - Full Feed
Needham & Company Maintains a 'Hold' on Par Pharmaceutical (PRX); Is Endo (ENDP) the 'Mystery Bidder'
August 24, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7683936 for the full story.
Read More
from
StreetInsider.com News Articles
VEA, NVS, BP, RDS.A: ETF Inflow Alert
August 21, 2012
Symbols mentioned in this story: VEA, NVS, BP, RDS. Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''.
Read More
category
ETFs
from
ETF Channel
Novartis: The Winning Streak Continues (NVS)
August 16, 2012
from
Comtex SmarTrend® News Briefs
Recent 52-Week High Exceeded in Shares of Novartis (NVS)
August 15, 2012
from
Comtex SmarTrend® News Briefs
VEA, NVS, BP, RDS.A: Large Inflows Detected at ETF
August 13, 2012
Symbols mentioned in this story: VEA, NVS, BP, RDS. Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''.
Read More
category
ETFs
from
ETF Channel
A Look At Two Undervalued Small-Cap Health Care Stocks
August 09, 2012
category
Pharmaceuticals
,
Unassigned
from
Trefis
Uh-Oh, Merck: FDA Approves Cheaper Versions of Singulair
August 06, 2012
Read More
category
NYSE:NVS
,
NYSE:MRK
,
NASDAQ:MYL
, and 2 more.
from
InvestorPlace - Latest Headlines
Recent 52-Week High Exceeded in Shares of Novartis (NVS)
August 06, 2012
from
Comtex SmarTrend® News Briefs
Novartis and University of Pennsylvania form broad-based RandD alliance to advance novel T-cell immunotherapies to treat cancer
August 06, 2012
Novartis and the University of Pennsylvania (Penn) announced today an exclusive global collaboration to research, develop and commercialize targeted chimeric antigen receptor (CAR) immunotherapies for...
Read More
category
Major Drugs
,
Healthcare
,
Launch
from
1888PressRelease - Full Feed
< Previous
1
2
3
4
5
6
7
8
9
...
76
77
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here